Frazier Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Frazier Management’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-199,953	Closed	-$408K	–	39
2020 Q3	$408K	Sell	199,953 -150,000	-43%	-$428K	0.04%	31
2020 Q2	$1.04M	Sell	349,953 -700,000	-67%	-$1.91M	0.09%	25
2020 Q1	$2.77M	Sell	1,049,953 -300,000	-22%	-$1.35M	0.31%	21
2019 Q4	$6.71M	Hold	1,349,953	–	–	1.13%	14
2019 Q3	$8.05M	Hold	1,349,953	–	–	2.52%	14
2019 Q2	$8.71M	Hold	1,349,953	–	–	2.23%	13
2019 Q1	$9.12M	Hold	1,349,953	–	–	2.2%	13
2018 Q4	$5.49M	Hold	1,349,953	–	–	1.42%	15
2018 Q3	$14.7M	Buy	+1,349,953	New	+$14.2M	2.69%	7

Other funds holding ETTX

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Frazier Management's ETTX Position: Q4 2020 in Review

Frazier Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 199,953 shares — an estimated $408K sold.

Frazier Management first reported a position in ETTX in Q3 2018 and held it in 9 quarters. The position peaked at $14.7M in Q3 2018. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

Frazier Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
Frazier Management sold 199,953 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $408K.
Frazier Management first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 9 quarters.
Frazier Management's Entasis Therapeutics Holdings Inc. position peaked at $14.7M in Q3 2018.
25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on Frazier Management's 13F filing for Q4 2020, filed 11 Feb 2021.